 |
|
|
|
 |
|
|
| Article 1 to 6 out of 6 concerning Cryptome Pharmaceuticals Ltd
|
-
Cryptome completes acquisition of HealthLinx
(02/21/2006)
Cryptome Pharmaceuticals Limited announced that it has completed the acquisition of HealthLinx Pty Ltd. HealthLinx, a privately held company before its acquisition, focuses on Biomarkers and the development of diagnostics, with its lead candidates ...
-
Melbourne Biotech Company to Unlock Milk Secrets
(11/10/2005)
Cryptome Pharmaceuticals Ltd will receive more than $850,000 from Dairy Australia over the next three years to conduct research that could unlock hidden pharmaceuticals and nutraceuticals in milk proteins. In-house expertise, state-of-the-art R&D ...
-
Cryptome and University of Virginia to expand vascular leak collaboration
(09/21/2005)
Cryptome Pharmaceuticals Ltd and the University of Virginia announced that they have signed an agreement to enable the further discovery of compounds to treat vascular leak. Leakage of fluid through blood vessel walls is an essential component of ...
-
Cryptome Discovers Novel Compounds to Treat Cancer
(08/02/2005)
Cryptome Pharmaceuticals Ltd announced that it has lodged a provisional patent application on a broad class of compounds to treat cancer. The compounds have been shown to inhibit growth of cancer cells and to inhibit angiogenesis in the laboratory. ...
-
Cryptome and NTRI to Work on Brain Trauma Drugs
(07/07/2005)
Cryptome Pharmaceuticals and the National Trauma Research Institute (NTRI) at The Alfred hospital, a member of Bayside Health, signed an agreement that will accelerate Cryptome's drug discovery platform in neuroinflammation. Using highly specialized ...
-
Xantos Biomedicine AG and Cryptome Pharmaceuticals Ltd collaborate to validate cancer lead
(06/21/2005)
Xantos Biomedicine AG announced that it has signed a collaboration agreement with Cryptome Pharmaceuticals Ltd, Melbourne, Australia. Xantos has used XantoScreen(TM) technology to discover novel proteins that mediate proliferation of vascular ...
|
|
|
|
|
Top
